Рыночные новости
Заголовки по акциям и крипте из Alpaca. Храним 7 дней. Всего: 9748.
-
Trex Company, Inc. Reports Q3 2026 Financial ResultsTrex Company, Inc. reported third-quarter 2026 revenue of $359.5 million and adjusted earnings per share of $0.55, both exceeding analyst expectations.
-
Oceaneering Participates in $1.8 Billion Cronos Field Development AgreementsOceaneering is among the international companies that signed agreements related to the development of the Cronos natural gas field offshore Cyprus.
-
Avista Corporation Reports Third Quarter 2026 Financial ResultsAvista Corporation announced its financial results for the third quarter of 2026, reporting net income of $49 million and confirming its full-year 2026 non-GAAP utility earnings guidance.
-
Viridian Therapeutics Reports Third Quarter 2026 Financial ResultsViridian Therapeutics announced its financial results for the third quarter ended September 30, 2026, highlighting the early launch performance of its drug Lumvoa.
-
ArcBest Corporation Reports Q3 2026 Financial ResultsArcBest Corporation reported third-quarter 2026 financial results, exceeding analyst expectations for both revenue and adjusted earnings per share.
-
Kyndryl Reports Second Quarter Fiscal 2027 ResultsKyndryl Holdings, Inc. announced its financial results for the second quarter of fiscal year 2027, reporting revenue of $3.7 billion and adjusted earnings per share of $0.42.
-
Freshpet, Inc. Reports Third Quarter 2026 Financial ResultsFreshpet, Inc. announced its financial results for the third quarter of 2026, reporting 10% net sales growth and raising its full-year outlook.
-
BTIG Raises AtriCure Price Target to $70BTIG maintained a Buy rating on AtriCure and increased its price target from $63 to $70.
-
IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations EventsIDEAYA Biosciences, Inc. announced its participation in upcoming investor relations events scheduled for November 2026.
-
StoneX Raises Cinemark Holdings Inc. Price Target to $45StoneX has increased its price target for Cinemark Holdings, Inc. from $40 to $45.
-
Analyst Adjusts Cinemark Price Target to $42An analyst has maintained a hold rating on Cinemark Holdings, Inc. while raising the price target from $31 to $42.
-
Aya Gold & Silver Reports New High-Grade Drill Results and Additional Permits at Boumadine ProjectAya Gold & Silver announced new high-grade drill results from its infill drill program at the Boumadine Project in Morocco and the acquisition of additional permits adjacent to the mining license.
-
Peyto Exploration & Development Boosts Monthly Dividend by 8%Peyto Exploration & Development Corp. has announced an 8% increase to its monthly dividend, raising the payout to C$0.13 per share.
-
Needham Maintains Buy Rating on IPG Photonics, Lowers Price Target to $105Needham has reaffirmed its 'Buy' rating on IPG Photonics while reducing the price target from $120 to $105.
-
WisdomTree Multi Asset Issuer PLC Announces Proposed Amendment to Silver 3x Daily Leveraged SecuritiesWisdomTree Multi Asset Issuer PLC has proposed an amendment to the principal amount of its WisdomTree Silver 3x Daily Leveraged Securities (ISIN: XS3306516876).
-
The Scotts Miracle-Gro Company Reports Fiscal 2026 Full-Year ResultsThe Scotts Miracle-Gro Company announced its financial results for the fourth quarter and full fiscal year ended September 30, 2026, reporting adjusted earnings per share that exceeded guidance.
-
Fastly, Inc. Announces Participation in Upcoming Investor ConferencesFastly, Inc. has confirmed its participation in three investor conferences scheduled for November and December 2026.
-
Truist Raises Price Target on Madrigal Pharmaceuticals to $743Truist has increased its price target for Madrigal Pharmaceuticals from $709 to $743 while maintaining a Buy rating on the stock.
-
USD.AI's SUSDAI Token Begins Spot Trading on Bullish ExchangeThe Bullish exchange has added support for SUSDAI, the token associated with the USD.AI permissionless lending protocol, for spot trading.
-
Cushman & Wakefield Reports Third Quarter 2026 Financial ResultsCushman & Wakefield announced its financial results for the third quarter of 2026, highlighting double-digit adjusted earnings growth and significant debt reduction.